HTTP/2 301
date: Sun, 18 Jan 2026 10:00:42 GMT
content-length: 0
location: https://doi.org/10.1101/385534
server: cloudflare
vary: Origin
expires: Mon, 19 Jan 2026 10:00:42 GMT
permissions-policy: interest-cohort=(),browsing-topics=()
cf-cache-status: DYNAMIC
nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800}
strict-transport-security: max-age=31536000; includeSubDomains; preload
report-to: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=jOAiYyw8CKnTeZBIhNNwnvIJfveWkv2SJJoUvSYd8i1Voqr%2BX4U%2BBr2XIivv3Th%2Fd3x6lZ0ZjOu6NnXvDlrabKO%2FuIoETw%3D%3D"}]}
cf-ray: 9bfd3f3119853585-BLR
alt-svc: h3=":443"; ma=86400
HTTP/2 302
date: Sun, 18 Jan 2026 10:00:42 GMT
content-type: text/html;charset=utf-8
location: https://biorxiv.org/lookup/doi/10.1101/385534
server: cloudflare
vary: Origin
vary: Accept
expires: Sun, 18 Jan 2026 10:07:48 GMT
permissions-policy: interest-cohort=(),browsing-topics=()
cf-cache-status: DYNAMIC
nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800}
strict-transport-security: max-age=31536000; includeSubDomains; preload
report-to: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=EXErkyZsv4HZTvgGieeTQNmG%2BnNFVVvF4gIPLqy4C9zPjJQqUo%2FR1k9TelwAUnaXruWZhBvUs%2FTUkxLb059tjV%2FKxpXgFg%3D%3D"}]}
cf-ray: 9bfd3f32cbab3585-BLR
alt-svc: h3=":443"; ma=86400
HTTP/1.1 302 Found
Date: Sun, 18 Jan 2026 10:00:43 GMT
Content-Type: text/html; charset=iso-8859-1
Transfer-Encoding: chunked
Connection: keep-alive
server: cloudflare
location: https://www.biorxiv.org/lookup/doi/10.1101/385534
cf-cache-status: DYNAMIC
Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800}
Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=zNubkas7XudUBbBvCFxUa6TVZItyfcuol3XWhtwPc6DlJmDqd2VCX1Hv7Q4e20APZ%2B2gwWhQiiC1K25m0w8lCNnaCmxa%2FhPARGry"}]}
CF-RAY: 9bfd3f334c93ff6a-BOM
alt-svc: h3=":443"; ma=86400
HTTP/2 301
date: Sun, 18 Jan 2026 10:00:44 GMT
content-type: text/html; charset=UTF-8
location: https://www.biorxiv.org/content/10.1101/385534v4
cf-ray: 9bfd3f369d0f58e1-BLR
x-content-type-options: nosniff
x-content-type-options: nosniff
x-drupal-cache: MISS
expires: Sun, 18 Jan 2026 10:30:44 GMT
cache-control: public, max-age=1800
pragma: no-cache
vary: Accept-Encoding
x-highwire-sitecode: biorxiv
x-highwire-smart-code: biorxiv_production
x-varnish: 1892489322
via: 1.1 varnish
x-varnish-ttl:
x-varnish-cache:
cf-cache-status: MISS
set-cookie: __cf_bm=FfCEnu0A4e.sIJwTF87xFqGdDM3YfhwLh_PYjwAuXWU-1768730444-1.0.1.1-DxVtwLbUSBtT2sSR0Unvn16Tm2MkSB8ZjT.hSsWhM5YzgmSzjvvq5yJGDjdsrHMw7U7ZM_g_gNnXHoSX._S4JRRZLnFhZZY.h2.OLUu.5XY; path=/; expires=Sun, 18-Jan-26 10:30:44 GMT; domain=.www.biorxiv.org; HttpOnly; Secure; SameSite=None
server: cloudflare
HTTP/2 200
date: Sun, 18 Jan 2026 10:00:46 GMT
content-type: text/html; charset=utf-8
content-encoding: gzip
x-content-type-options: nosniff
x-content-type-options: nosniff
x-drupal-cache: MISS
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
set-cookie: SSESS1dd6867f1a1b90340f573dcdef3076bc=PyUpel3jizvNxurw9u9RHXu_6MbSZx5aMn9tdwQSYP4; expires=Tue, 10-Feb-2026 13:34:04 GMT; path=/; domain=.biorxiv.org; secure; HttpOnly
content-language: en
x-frame-options: SAMEORIGIN
x-generator: Drupal 7 (https://drupal.org)
link:
; rel="canonical",; rel="shortlink"
vary: Accept-Encoding
x-highwire-sitecode: biorxiv
x-highwire-smart-code: biorxiv_production
x-varnish: 694617580
age: 0
via: 1.1 varnish
x-varnish-ttl:
x-varnish-cache:
cf-cache-status: DYNAMIC
server: cloudflare
cf-ray: 9bfd3f3ede1a58e1-BLR
Parameter tuning is a key part of dimensionality reduction via deep variational autoencoders for single cell RNA transcriptomics | bioRxiv
New Results
Parameter tuning is a key part of dimensionality reduction via deep variational autoencoders for single cell RNA transcriptomics
doi: https://doi.org/10.1101/385534

Abstract
Single-cell RNA sequencing (scRNA-seq) is a powerful tool to profile the transcriptomes of a large number of individual cells at a high resolution. These data usually contain measurements of gene expression for many genes in thousands or tens of thousands of cells, though some datasets now reach the million-cell mark. Projecting high-dimensional scRNA-seq data into a low dimensional space aids downstream analysis and data visualization. Many recent preprints accomplish this using variational autoencoders (VAE), generative models that learn underlying structure of data by compress it into a constrained, low dimensional space. The low dimensional spaces generated by VAEs have revealed complex patterns and novel biological signals from large-scale gene expression data and drug response predictions. Here, we evaluate a simple VAE approach for gene expression data, Tybalt, by training and measuring its performance on sets of simulated scRNA-seq data. We find a number of counter-intuitive performance features: i.e., deeper neural networks can struggle when datasets contain more observations under some parameter configurations. We show that these methods are highly sensitive to parameter tuning: when tuned, the performance of the Tybalt model, which was not optimized for scRNA-seq data, outperforms other popular dimension reduction approaches – PCA, ZIFA, UMAP and t-SNE. On the other hand, without tuning performance can also be remarkably poor on the same data. Our results should discourage authors and reviewers from relying on self-reported performance comparisons to evaluate the relative value of contributions in this area at this time. Instead, we recommend that attempts to compare or benchmark autoencoder methods for scRNA-seq data be performed by disinterested third parties or by methods developers only on unseen benchmark data that are provided to all participants simultaneously because the potential for performance differences due to unequal parameter tuning is so high.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license.